 Curtis Coughlin II
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 15 | 2024 | 333 | 4.380 |
Why?
| | Pyridoxine | 10 | 2024 | 36 | 2.990 |
Why?
| | Aldehyde Dehydrogenase | 9 | 2024 | 100 | 2.210 |
Why?
| | Neonatal Screening | 4 | 2024 | 169 | 2.090 |
Why?
| | Lysine | 8 | 2024 | 294 | 1.680 |
Why?
| | Hyperglycinemia, Nonketotic | 7 | 2019 | 51 | 1.630 |
Why?
| | Arginine | 4 | 2020 | 271 | 1.280 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 3 | 2023 | 24 | 1.090 |
Why?
| | Pipecolic Acids | 4 | 2024 | 26 | 1.090 |
Why?
| | Brain Diseases, Metabolic | 2 | 2023 | 8 | 1.000 |
Why?
| | Disclosure | 4 | 2023 | 113 | 0.820 |
Why?
| | Genetic Counseling | 3 | 2023 | 77 | 0.800 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 2015 | 19 | 0.790 |
Why?
| | Vitamin B Complex | 2 | 2022 | 44 | 0.650 |
Why?
| | Infant, Newborn | 19 | 2024 | 6079 | 0.610 |
Why?
| | Dietary Supplements | 2 | 2020 | 561 | 0.590 |
Why?
| | Mutation, Missense | 4 | 2016 | 341 | 0.570 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.520 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.520 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 8 | 0.520 |
Why?
| | Seizures | 4 | 2022 | 426 | 0.480 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.460 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.460 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.460 |
Why?
| | Brain Diseases | 2 | 2020 | 141 | 0.460 |
Why?
| | Genetic Testing | 6 | 2023 | 460 | 0.430 |
Why?
| | Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2010 | 3 | 0.420 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 200 | 0.410 |
Why?
| | Sudden Infant Death | 2 | 2010 | 29 | 0.400 |
Why?
| | Mitochondria | 2 | 2020 | 948 | 0.390 |
Why?
| | Hyperargininemia | 2 | 2018 | 2 | 0.390 |
Why?
| | Chromosomes, Human, Pair 16 | 2 | 2021 | 36 | 0.390 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 181 | 0.380 |
Why?
| | Glutaryl-CoA Dehydrogenase | 2 | 2023 | 5 | 0.380 |
Why?
| | Humans | 52 | 2024 | 137585 | 0.380 |
Why?
| | Amino Acids | 1 | 2015 | 497 | 0.360 |
Why?
| | Glycine | 3 | 2017 | 176 | 0.350 |
Why?
| | Biomarkers | 5 | 2024 | 4149 | 0.350 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.340 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2010 | 6 | 0.330 |
Why?
| | Mutation | 8 | 2020 | 3958 | 0.330 |
Why?
| | Urinary Tract | 1 | 2010 | 51 | 0.330 |
Why?
| | Sequence Deletion | 1 | 2010 | 183 | 0.330 |
Why?
| | Mosaicism | 1 | 2010 | 73 | 0.320 |
Why?
| | Hirschsprung Disease | 1 | 2010 | 88 | 0.310 |
Why?
| | Muscular Diseases | 1 | 2010 | 114 | 0.310 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 91 | 0.310 |
Why?
| | Energy Metabolism | 1 | 2015 | 922 | 0.300 |
Why?
| | Primary Health Care | 1 | 2019 | 1738 | 0.300 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1457 | 0.290 |
Why?
| | Diet Therapy | 2 | 2020 | 37 | 0.290 |
Why?
| | DNA Mutational Analysis | 4 | 2015 | 399 | 0.280 |
Why?
| | Infant | 17 | 2024 | 9465 | 0.270 |
Why?
| | Male | 28 | 2024 | 67762 | 0.270 |
Why?
| | Tandem Mass Spectrometry | 2 | 2024 | 532 | 0.250 |
Why?
| | Hypoglycemia | 2 | 2010 | 445 | 0.250 |
Why?
| | Liver | 3 | 2023 | 1943 | 0.240 |
Why?
| | Arginase | 1 | 2015 | 32 | 0.240 |
Why?
| | 2-Aminoadipic Acid | 3 | 2024 | 8 | 0.240 |
Why?
| | Genetic Diseases, X-Linked | 2 | 2017 | 24 | 0.240 |
Why?
| | Genetic Variation | 2 | 2015 | 991 | 0.240 |
Why?
| | Genetic Diseases, Inborn | 1 | 2015 | 44 | 0.230 |
Why?
| | Cognition | 3 | 2022 | 1153 | 0.230 |
Why?
| | Heterozygote | 4 | 2020 | 293 | 0.230 |
Why?
| | Child, Preschool | 15 | 2024 | 11074 | 0.220 |
Why?
| | Dried Blood Spot Testing | 1 | 2024 | 104 | 0.220 |
Why?
| | Databases, Genetic | 1 | 2015 | 237 | 0.210 |
Why?
| | Glutarates | 1 | 2023 | 10 | 0.210 |
Why?
| | Counselors | 1 | 2023 | 13 | 0.210 |
Why?
| | Acidosis, Lactic | 3 | 2020 | 46 | 0.200 |
Why?
| | Female | 25 | 2024 | 73304 | 0.200 |
Why?
| | Genome, Human | 1 | 2015 | 425 | 0.200 |
Why?
| | Phenotype | 6 | 2020 | 3196 | 0.200 |
Why?
| | Leigh Disease | 2 | 2020 | 21 | 0.200 |
Why?
| | Kidney | 1 | 2010 | 1468 | 0.200 |
Why?
| | Gene Expression | 2 | 2020 | 1502 | 0.190 |
Why?
| | Genotype | 2 | 2019 | 1916 | 0.190 |
Why?
| | Hyperammonemia | 2 | 2016 | 16 | 0.190 |
Why?
| | Urea Cycle Disorders, Inborn | 2 | 2019 | 23 | 0.190 |
Why?
| | Child | 17 | 2024 | 21935 | 0.190 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2426 | 0.180 |
Why?
| | Intellectual Disability | 2 | 2021 | 165 | 0.180 |
Why?
| | Motor Disorders | 1 | 2021 | 15 | 0.180 |
Why?
| | Segmental Duplications, Genomic | 1 | 2021 | 8 | 0.180 |
Why?
| | Metabolism | 1 | 2021 | 42 | 0.180 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 12 | 0.180 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 41 | 0.180 |
Why?
| | Williams Syndrome | 1 | 2021 | 13 | 0.180 |
Why?
| | Chromosome Disorders | 1 | 2021 | 43 | 0.170 |
Why?
| | Feasibility Studies | 1 | 2024 | 956 | 0.170 |
Why?
| | Craniofacial Abnormalities | 1 | 2021 | 72 | 0.170 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.170 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.170 |
Why?
| | International Cooperation | 1 | 2020 | 198 | 0.160 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2020 | 108 | 0.160 |
Why?
| | Anticonvulsants | 1 | 2022 | 217 | 0.160 |
Why?
| | 22q11 Deletion Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 44 | 0.160 |
Why?
| | Orphan Drug Production | 1 | 2019 | 5 | 0.160 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2019 | 45 | 0.160 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.160 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2019 | 113 | 0.150 |
Why?
| | Tryptophan | 1 | 2020 | 183 | 0.150 |
Why?
| | Protein Subunits | 1 | 2020 | 239 | 0.150 |
Why?
| | Fatal Outcome | 4 | 2016 | 303 | 0.150 |
Why?
| | Receptors, GABA-A | 1 | 2020 | 142 | 0.150 |
Why?
| | Corpus Callosum | 1 | 2019 | 71 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 146 | 0.150 |
Why?
| | Rare Diseases | 1 | 2019 | 104 | 0.150 |
Why?
| | Argininosuccinic Aciduria | 1 | 2018 | 2 | 0.150 |
Why?
| | Citrullinemia | 1 | 2018 | 2 | 0.150 |
Why?
| | Chromosome Mapping | 1 | 2019 | 523 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 4 | 2020 | 3566 | 0.140 |
Why?
| | Communication | 2 | 2021 | 879 | 0.140 |
Why?
| | Amino Acid Sequence | 3 | 2020 | 2139 | 0.140 |
Why?
| | Consensus | 1 | 2020 | 683 | 0.140 |
Why?
| | Orotidine-5'-Phosphate Decarboxylase | 1 | 2017 | 1 | 0.140 |
Why?
| | Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 2017 | 2 | 0.140 |
Why?
| | Orotate Phosphoribosyltransferase | 1 | 2017 | 2 | 0.140 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 11 | 0.130 |
Why?
| | Alleles | 2 | 2020 | 891 | 0.130 |
Why?
| | NADH Dehydrogenase | 1 | 2017 | 19 | 0.130 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 433 | 0.130 |
Why?
| | White Matter | 1 | 2019 | 145 | 0.130 |
Why?
| | Bariatric Surgery | 1 | 2020 | 217 | 0.130 |
Why?
| | Methylmalonic Acid | 1 | 2017 | 65 | 0.130 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 68 | 0.130 |
Why?
| | Electron Transport Complex I | 1 | 2017 | 41 | 0.130 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.130 |
Why?
| | Point Mutation | 1 | 2017 | 235 | 0.130 |
Why?
| | Obesity, Morbid | 1 | 2020 | 264 | 0.130 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2017 | 81 | 0.130 |
Why?
| | Cohort Studies | 3 | 2022 | 5742 | 0.130 |
Why?
| | Sodium Benzoate | 1 | 2016 | 5 | 0.130 |
Why?
| | Vascular Malformations | 1 | 2016 | 52 | 0.120 |
Why?
| | Dextromethorphan | 1 | 2016 | 18 | 0.120 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2016 | 100 | 0.120 |
Why?
| | Informed Consent | 3 | 2023 | 175 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 31 | 0.120 |
Why?
| | Zebrafish | 1 | 2020 | 499 | 0.120 |
Why?
| | Portal Vein | 1 | 2016 | 120 | 0.120 |
Why?
| | Aminoacylation | 1 | 2015 | 14 | 0.120 |
Why?
| | Introns | 1 | 2016 | 258 | 0.120 |
Why?
| | Motor Activity | 1 | 2020 | 718 | 0.120 |
Why?
| | Dyskinesias | 1 | 2015 | 19 | 0.120 |
Why?
| | Exons | 1 | 2016 | 355 | 0.120 |
Why?
| | Homocystinuria | 1 | 2015 | 71 | 0.110 |
Why?
| | Siblings | 1 | 2016 | 228 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 92 | 0.110 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1587 | 0.110 |
Why?
| | Cell Respiration | 1 | 2015 | 103 | 0.110 |
Why?
| | Electron Transport | 1 | 2015 | 115 | 0.110 |
Why?
| | Sequence Alignment | 1 | 2015 | 343 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.110 |
Why?
| | Sulfurtransferases | 1 | 2013 | 10 | 0.110 |
Why?
| | Glutaredoxins | 1 | 2013 | 13 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2015 | 138 | 0.110 |
Why?
| | Time-to-Treatment | 1 | 2016 | 205 | 0.110 |
Why?
| | Genetic Association Studies | 2 | 2020 | 377 | 0.110 |
Why?
| | Exome | 1 | 2015 | 231 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 326 | 0.110 |
Why?
| | Genes, X-Linked | 1 | 2013 | 18 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 15 | 0.110 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.100 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2900 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2021 | 842 | 0.100 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2017 | 350 | 0.100 |
Why?
| | Vitamin B 12 | 1 | 2013 | 128 | 0.100 |
Why?
| | Osteoporosis | 1 | 2015 | 243 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 1101 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1066 | 0.090 |
Why?
| | Health Personnel | 1 | 2018 | 710 | 0.090 |
Why?
| | Bone Density | 1 | 2015 | 489 | 0.090 |
Why?
| | Brain | 3 | 2017 | 2668 | 0.090 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 153 | 0.090 |
Why?
| | Child Development | 1 | 2016 | 475 | 0.090 |
Why?
| | Ear | 1 | 2010 | 34 | 0.080 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 73 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 1002 | 0.080 |
Why?
| | Cerebral Cortex | 1 | 2012 | 433 | 0.080 |
Why?
| | Amino Acid Substitution | 1 | 2010 | 307 | 0.080 |
Why?
| | Adolescent | 7 | 2021 | 21513 | 0.080 |
Why?
| | Cystinuria | 1 | 2008 | 4 | 0.080 |
Why?
| | Penicillamine | 1 | 2008 | 23 | 0.080 |
Why?
| | Urinary Calculi | 1 | 2008 | 12 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 767 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2022 | 15657 | 0.070 |
Why?
| | Longitudinal Studies | 3 | 2018 | 2844 | 0.070 |
Why?
| | Proteins | 1 | 2013 | 1009 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2181 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2020 | 327 | 0.060 |
Why?
| | Macaca fascicularis | 1 | 2015 | 65 | 0.060 |
Why?
| | National Library of Medicine (U.S.) | 1 | 2015 | 6 | 0.060 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 1 | 2024 | 23 | 0.060 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 1431 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 2189 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2018 | 1023 | 0.050 |
Why?
| | United States | 4 | 2020 | 14841 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1353 | 0.050 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 8 | 0.040 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 37 | 0.040 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 55 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.040 |
Why?
| | Recommended Dietary Allowances | 1 | 2020 | 18 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2021 | 115 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 155 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 60 | 0.040 |
Why?
| | Chromosomal Instability | 1 | 2019 | 19 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 185 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 203 | 0.040 |
Why?
| | Public-Private Sector Partnerships | 1 | 2019 | 43 | 0.040 |
Why?
| | Locomotion | 1 | 2020 | 106 | 0.040 |
Why?
| | Larva | 1 | 2020 | 226 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2019 | 128 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5472 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.040 |
Why?
| | Primates | 1 | 2019 | 126 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2022 | 413 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 350 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2019 | 317 | 0.040 |
Why?
| | Genetics | 1 | 2018 | 23 | 0.040 |
Why?
| | Drug Industry | 1 | 2019 | 111 | 0.040 |
Why?
| | Animals | 4 | 2020 | 36940 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 263 | 0.040 |
Why?
| | Confidentiality | 1 | 2018 | 73 | 0.040 |
Why?
| | Ammonia | 1 | 2018 | 62 | 0.030 |
Why?
| | Young Adult | 3 | 2021 | 13209 | 0.030 |
Why?
| | Citrulline | 1 | 2018 | 45 | 0.030 |
Why?
| | Glutamine | 1 | 2018 | 103 | 0.030 |
Why?
| | Orotic Acid | 1 | 2017 | 2 | 0.030 |
Why?
| | Anemia, Megaloblastic | 1 | 2017 | 9 | 0.030 |
Why?
| | Uridine | 1 | 2017 | 30 | 0.030 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2017 | 43 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 39 | 0.030 |
Why?
| | Autopsy | 1 | 2016 | 95 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1670 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 672 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1060 | 0.030 |
Why?
| | Intelligence Tests | 1 | 2016 | 57 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 1020 | 0.030 |
Why?
| | Family | 1 | 2020 | 671 | 0.030 |
Why?
| | Risk Factors | 1 | 2010 | 10388 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
| | Adult | 4 | 2021 | 37929 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2019 | 493 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 91 | 0.030 |
Why?
| | Language | 1 | 2018 | 292 | 0.030 |
Why?
| | Homocysteine | 1 | 2015 | 156 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 188 | 0.030 |
Why?
| | Methionine | 1 | 2015 | 160 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4295 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 787 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 259 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 242 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5757 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 374 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2847 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 246 | 0.030 |
Why?
| | Pyrimidines | 1 | 2017 | 470 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 184 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 12 | 0.030 |
Why?
| | Students | 1 | 2018 | 622 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1483 | 0.020 |
Why?
| | Mental Disorders | 1 | 2021 | 1077 | 0.020 |
Why?
| | Age of Onset | 1 | 2013 | 518 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 257 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 622 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 900 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 730 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1118 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1303 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2010 | 53 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 427 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2031 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7604 | 0.020 |
Why?
| | Mice | 1 | 2015 | 17787 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5778 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2224 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 4030 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2828 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4565 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2833 | 0.010 |
Why?
| | Middle Aged | 2 | 2018 | 33479 | 0.010 |
Why?
| | Diet | 1 | 2012 | 1278 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2607 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2691 | 0.010 |
Why?
|
|
Coughlin II's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|